Repadax 1 – Repaglinide Tablets IP 1 mg – 1 × 10 Tablets

Repadax 1 Tablets are an advanced oral hypoglycemic medication precisely engineered for the management of Type 2 Diabetes Mellitus, with a primary clinical focus on controlling post-prandial glucose surges. This intermediate 1 mg strength is ideal for tailored therapy setups, flexible mealtime titration, or as a core component in a combination therapy protocol alongside long-acting anti-diabetic compounds like metformin.

Repaglinide operates via a rapid, meal-dependent mechanism as a non-sulfonylurea insulin secretagogue. It binds to distinct ATP-dependent potassium channels on the membrane of pancreatic beta-cells. This mechanical action closes the potassium channels, triggering cellular depolarization and opening voltage-gated calcium channels. The resulting influx of calcium ions induces a swift, short-acting release of pre-stored insulin. Because Repadax 1 acts quickly and has a short therapeutic duration, it precisely mimics the body’s natural phase-1 insulin response to food intake, efficiently moving glucose out of the bloodstream into muscle and fat tissues precisely when it is needed most, minimizing the risk of prolonged background low blood sugar.

Key Benefits

• Fast-Acting Mealtime Control: Targets post-meal blood sugar spikes with a rapid onset of action.

• Prandial Glucose Regulation: Stimulates insulin secretion in direct response to food intake for a more physiological metabolic cycle.

• Flexible Dosing Layout: Short half-life means it can be titrated directly to shifting daily meal schedules or specific carbohydrate tracking.

• Prevents Long-Term Risks: Tight control over daily sugar fluctuations reduces secondary complications like kidney impairment or retinal damage.

• Trusted Quality: Manufactured by Daxia Healthcare to meet precise pharmaceutical uniformity and reliable active ingredient dissolution standards.

Directions for Use

• Take exactly as directed by your healthcare routine or endocrinologist.

• Repadax 1 must be taken orally before meals—usually within 15 to 30 minutes before starting a main meal.

• Important Rule: “An extra meal means an extra dose; a missed meal means a skipped dose.” If you skip a major meal, do not take the scheduled tablet to avoid low blood sugar.

• Swallow the tablet whole with a glass of water. Do not crush or chew it.

Safety & Precautions

• Risk of Hypoglycemia (Low Blood Sugar): This medicine lowers blood sugar rapidly. Always carry a quick source of glucose, sugar candy, or fruit juice in case you experience signs of low blood sugar (such as sudden sweating, shaking, dizziness, intense hunger, confusion, or blurred vision).

• Regular tracking of blood glucose parameters and periodic HbA1c testing are highly recommended to ensure safe therapy maintenance.

• Contraindicated for individuals with Type 1 Diabetes (insulin-dependent) or diabetic ketoacidosis.

• Inform your specialist if you have moderate-to-severe liver or kidney dysfunction before initiating treatment, as clearance parameters may differ.

• Keep out of reach of children.

Storage

• Store in a cool, dry place below 30°C.

• Protect from direct sunlight, excessive heat, and ambient room moisture.

• Keep the tablets safely stored inside their original protective blister pack configuration until the time of consumption.